Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug-gene interactions in older patients with coronary artery disease.

BMC geriatrics - 26 Oct 2024

Zhang Shizhao, Lv Chao, Dong Lisha, Wu Yangxun, Yin Tong

Abstract excerpt

BACKGROUND: Older patients with coronary artery disease (CAD) are particularly vulnerable to the efficacy and adverse drug reactions, and may therefore particularly benefit from personalized medication. Drug-gene interactions (DGIs) occur when an individual's genotype affects the pharmacokinetics and/or pharmacodynamics of a victim drug. OBJECTIVES: This study aimed to investigate the impact of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Cardiovascular Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Coronary Artery Disease

Share to Genotype

Share to Pharmacogenetics

Share to Pharmacogenomic Variants

Source

Open in PubMed Open full text

Identifiers

PMID: 39462319
DOI: 10.1186/s12877-024-05471-7
PMCID: PMC11515805

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug-gene interactions in older patients with coronary artery disease.PMID 39462319Read ↗

Drug-gene interactions in older patients with coronary artery diseaseSemantic proximity Read ↗

Use of pharmacogenomics in elderly patients treated for cardiovascular diseasesSemantic proximity Read ↗

Pharmacogenomics in Cardiovascular Diseases.Semantic proximity Read ↗

Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments.Semantic proximity Read ↗

Pharmacogenetics of clopidogrel and warfarin in the treatment of cardiovascular diseases: an overview of reviews.Semantic proximity Read ↗

Cardiovascular pharmacogenomics: current status and future directions.Semantic proximity Read ↗

Cardiovascular drugs and the genetic response.Semantic proximity Read ↗

Drug-gene interactions and the risk of diabetic microvascular complications: A population-based cohort study.Semantic proximity Read ↗

Pharmacogenomics of drugs affecting the cardiovascular system.Semantic proximity Read ↗

Use of Drugs With Actionable Pharmacogenetic Biomarkers and Possible Prescribing Changes Among Older People.Semantic proximity Read ↗

Genetic determinants of response to cardiovascular drugs.Semantic proximity Read ↗

The ABCD-GENE score influences vascular event rates in both users of clopidogrel and aspirin, as well as non-users of either drug in a population-based cohort studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.